Expression and Prognostic Relevance of GAGE1 and XAGE1 Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma

2018 ◽  
Vol 17 (10) ◽  
pp. 707-717 ◽  
Author(s):  
B.T.R. Karia ◽  
F.T. Zamuner ◽  
V. Carlin ◽  
C.Z. de Oliveira ◽  
A.L. Carvalho ◽  
...  
2015 ◽  
Vol 14 (3) ◽  
pp. 828-834 ◽  
Author(s):  
Fernando Tadeu Zamunér ◽  
Bruno Takao Real Karia ◽  
Cleyton Zanardo de Oliveira ◽  
Carlos Roberto dos Santos ◽  
André Lopes Carvalho ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (22) ◽  
pp. 5690
Author(s):  
Sharon Changshan Wu ◽  
Karl Münger

Cancer/testis (CT) antigens exhibit selective expression predominantly in immunoprivileged tissues in non-pathological contexts but are aberrantly expressed in diverse cancers. Due to their expression pattern, they have historically been attractive targets for immunotherapies. A growing number of studies implicate CT antigens in almost all hallmarks of cancer, suggesting that they may act as cancer drivers. CT antigens are expressed in head and neck squamous cell carcinomas. However, their role in the pathogenesis of these cancers remains poorly studied. Given that CT antigens hold intriguing potential as therapeutic targets and as biomarkers for prognosis and that they can provide novel insights into oncogenic mechanisms, their further study in the context of head and squamous cell carcinoma is warranted.


2011 ◽  
Author(s):  
Fernando T. Zamunér ◽  
Bruno Takao Real Karia ◽  
André Lopes Carvalho ◽  
André Luiz Vettore de Oliveira

2010 ◽  
Vol 128 (11) ◽  
pp. 2625-2634 ◽  
Author(s):  
Cyril Cuffel ◽  
Jean-Paul Rivals ◽  
Yannick Zaugg ◽  
Suzanne Salvi ◽  
Walter Seelentag ◽  
...  

Author(s):  
Sharon Chanshan Wu ◽  
Karl Munger

Cancer/testis (CT) antigens exhibit selective expression predominantly in immunoprivileged tissues in non-pathological contexts but are aberrantly expressed in diverse cancers. Because of their expression pattern, they have historically been attractive targets for immunotherapies. The investigation of mechanistic roles of CT antigens in promoting oncogenesis has historically been a prominent research question, and a growing number of studies implicate CT antigens in promoting almost all the hallmarks of cancer. This suggests that CT antigens may act as cancer drivers. CT antigens are expressed in head and neck squamous cell carcinomas, although their role in the pathogenesis, prognostication, and treatment for this family of cancers remains poorly studied. Given that CT antigens hold intriguing potential as therapeutic targets and as biomarkers for prognosis and therapeutic response and that they can provide novel insights into oncogenic mechanisms, their further study in the context of head and squamous cell carcinoma is warranted.


Oncotarget ◽  
2017 ◽  
Vol 8 (59) ◽  
pp. 100280-100287 ◽  
Author(s):  
Christopher A. Schutt ◽  
Leonardo Mirandola ◽  
Jose A. Figueroa ◽  
Diane D. Nguyen ◽  
Joehassin Cordero ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document